medroxyprogesterone acetate has been researched along with Fibroid in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.88) | 18.7374 |
1990's | 22 (53.66) | 18.2507 |
2000's | 7 (17.07) | 29.6817 |
2010's | 8 (19.51) | 24.3611 |
2020's | 2 (4.88) | 2.80 |
Authors | Studies |
---|---|
Baird, DD; Cooper, TE; Harmon, QE; Patchel, SA; Umbach, DM; Zhao, S | 1 |
Lumbiganon, P; Pattanittum, P; Sangkomkamhang, US | 1 |
Chiang, W; Hsia, SM; Lin, PH; Shih, CK; Yen, YT | 1 |
Laopaiboon, M; Lumbiganon, P; Mol, BW; Sangkomkamhang, US | 1 |
McLaren, JS; Morris, EP; Rymer, J; Simpson, PD | 1 |
Baird, DD; Harmon, QE | 1 |
Martínez-Uribe, A; Olvera-Maldonado, AJ; Rendón-Macías, ME; Sangines-Martínez, A | 1 |
Britten, J; Catherino, WH; Cox, J; Malik, M; Patel, A | 1 |
Abraham, T; Arian, SE; Bartels, CB; Cayton, KC; Chuong, FS; Holthouser, K; Segars, JH | 1 |
Bristow, RE; Gu, M; Kratz, KG; Santillan, A | 1 |
Baird, DD; Davis, B; Garrett, TA; Laughlin, SK; Peddada, SD; Semelka, RC | 1 |
Chegini, N; Ma, C; Tang, XM; Williams, RS | 1 |
Fletcher, H; Johnson, N; Reid, M | 1 |
Bagratee, JS; Moodley, J; Venkatachalam, S | 1 |
Honma, H; Komura, H; Mizutani, T; Nakamuro, K; Sugihara, A; Terada, N | 1 |
Jestila, KJ; Scialli, AR | 1 |
Cartmell, L; Siegle, JC | 1 |
Ishimaru, T; Masuzaki, H; Samejima, T | 1 |
Kida, H; Minaguchi, H; Saji, M; Sakakibara, H; Taga, M | 1 |
Andersen, J; Barbieri, RL; Brink, PR; Chumas, JC; Eng, CL; Grine, E; Zhao, K | 1 |
Colacurci, N; De Placido, G; Locci, M; Montemagno, U; Zullo, F | 1 |
Cohen, JD; Robins, HI | 1 |
Bradshaw, KD; Breslau, NA; Byrd, W; Carr, BR; Marshburn, PB; Roark, M; Steinkampf, MP; Weatherall, PT | 1 |
Doğu, N; Ekici, E; Gökmen, O; Ozmen, S; Seçkin, NC; Sener, AB | 1 |
Chegini, N; Dou, Q; Kipersztok, S; Rong, H; Williams, RS | 1 |
Bäckström, AC; Granberg, S; Hirsjärvi-Lahti, T; Ylöstalo, P | 1 |
Caird, LE; Gow, SM; Hannan, WJ; Lumsden, MA; West, CP | 1 |
Bassaw, K; Gangar, K | 1 |
Altieri, P; de Aloysio, D; Penacchioni, P; Salgarello, M; Ventura, V | 1 |
Boubli, L | 1 |
D'Altorio, C; Di Biase, S; Lanzilotti, G; Orsini, G; Pinto, V | 1 |
Colleoni, R; Nappi, RE; Polatti, F; Viazzo, F | 1 |
Mastrantonio, P; Morelli, M; Noia, R; Palomba, S; Sena, T; Zullo, F | 1 |
Diedrich, K; Naether, O | 1 |
Baird, DT; Lumsden, MA; West, CP | 1 |
Blanchet, P; Friede, J; Lemay, A; Maheux, R; Pratt, X | 1 |
Brooks, PG; Serden, SP | 1 |
Abbondante, G; Aleandri, V; Benagiano, G; Elkind-Hirsch, K; Morini, A; Piccinno, F; Primiero, FM | 1 |
Barbieri, RL | 1 |
Friedman, AJ | 1 |
Barbieri, RL; Doubilet, PM; Fine, C; Friedman, AJ; Schiff, I | 1 |
6 review(s) available for medroxyprogesterone acetate and Fibroid
Article | Year |
---|---|
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Topics: Adult; Antineoplastic Agents, Hormonal; Bias; Contraceptives, Oral; Desogestrel; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Nandrolone; Norethindrone Acetate; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2020 |
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2013 |
Minimising menopausal side effects whilst treating endometriosis and fibroids.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Contraceptives, Oral, Combined; Delayed-Action Preparations; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Receptors, LHRH; Uterine Neoplasms | 2015 |
An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.
Topics: Androgens; Aromatase Inhibitors; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Curcumin; Delayed-Action Preparations; Drugs, Chinese Herbal; Estradiol; Estrenes; Estrogen Receptor Antagonists; Evidence-Based Medicine; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Neoadjuvant Therapy; Norpregnadienes; Oximes; Plant Extracts; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tea; Uterine Myomectomy; Uterine Neoplasms; Vitamin D; Vitamins | 2016 |
[Drug treatment of uterine fibromas].
Topics: Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Progestins; Uterine Neoplasms | 1999 |
Goserelin (Zoladex) in the treatment of fibroids.
Topics: Buserelin; Combined Modality Therapy; Drug Therapy, Combination; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estradiol; Tamoxifen; Uterine Neoplasms | 1992 |
14 trial(s) available for medroxyprogesterone acetate and Fibroid
Article | Year |
---|---|
[Medical treatment of the uterine miomas in perimenopausal patients].
Topics: Antineoplastic Agents, Hormonal; Female; Humans; Hysterectomy; Leiomyoma; Longitudinal Studies; Medroxyprogesterone Acetate; Middle Aged; Perimenopause; Prospective Studies; Treatment Outcome; Uterine Neoplasms | 2015 |
Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
Topics: Adult; Antineoplastic Agents, Hormonal; Cell Proliferation; Drug Administration Schedule; Estrogens, Conjugated (USP); Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Treatment Outcome; Uterine Neoplasms | 2005 |
Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri.
Topics: Adult; Double-Blind Method; Female; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms | 1995 |
GnRHa and steroid add-back therapy for uterine myoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Time Factors; Uterine Neoplasms | 1995 |
An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
Topics: Adult; Double-Blind Method; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Luteinizing Hormone; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Middle Aged; Placebos; Prospective Studies; Triptorelin Pamoate; Uterine Neoplasms | 1993 |
The effects of hormone replacement therapy on uterine fibroids in postmenopausal women.
Topics: Antineoplastic Agents, Hormonal; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Postmenopause; Uterine Neoplasms | 1996 |
Uterine findings by transvaginal sonography during percutaneous estrogen treatment in postmenopausal women.
Topics: Case-Control Studies; Drug Administration Schedule; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Time Factors; Ultrasonography; Uterine Neoplasms; Uterus | 1996 |
Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability.
Topics: Adult; Amino Acids; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Density; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms; Uterus | 1997 |
Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT.
Topics: Anabolic Agents; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Uterine Neoplasms | 1998 |
[The effects of menopausal replacement therapy in women with uterine myomas].
Topics: Antineoplastic Agents, Hormonal; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Time Factors; Uterine Neoplasms | 1999 |
Uterine myoma in postmenopause: a comparison between two therapeutic schedules of HRT.
Topics: Administration, Cutaneous; Administration, Oral; Cyproterone Acetate; Drug Administration Schedule; Estradiol; Female; Hormone Replacement Therapy; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Prospective Studies; Ultrasonography; Uterine Neoplasms | 2000 |
Effect of different doses of progestin on uterine leiomyomas in postmenopausal women.
Topics: Amenorrhea; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Postmenopause; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms | 2002 |
Sequential Gn-RH superagonist and medroxyprogesterone acetate treatment of uterine leiomyomata.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Delayed-Action Preparations; Female; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Time Factors; Ultrasonography; Uterine Neoplasms | 1990 |
A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri.
Topics: Adult; Antineoplastic Agents; Cholesterol; Double-Blind Method; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Random Allocation; Uterine Neoplasms | 1988 |
21 other study(ies) available for medroxyprogesterone acetate and Fibroid
Article | Year |
---|---|
Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma.
Topics: Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Incidence; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate | 2022 |
Adlay (
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Coix; Diethylstilbestrol; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Mice; Phosphorylation; Plant Extracts; Rats; Uterine Neoplasms | 2019 |
Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women.
Topics: Adult; Black or African American; Cohort Studies; Confidence Intervals; Cross-Sectional Studies; Delayed-Action Preparations; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Odds Ratio; Prevalence; Protective Agents; Ultrasonography; Uterine Diseases | 2015 |
Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
Topics: Antineoplastic Agents, Hormonal; Cell Culture Techniques; Cell Line, Tumor; Collagen Type I; Estradiol; Extracellular Matrix; Female; Fibronectins; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Time Factors; Uterine Neoplasms; Versicans | 2016 |
Radical surgical cytoreduction of progressive leiomyomatosis peritonealis disseminata: a case report.
Topics: Adult; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Leiomyoma; Leiomyomatosis; Medroxyprogesterone Acetate; Peritoneal Cavity; Peritoneal Neoplasms | 2009 |
Short-term change in growth of uterine leiomyoma: tumor growth spurts.
Topics: Adult; Black People; Cell Division; Disease Progression; Estrogens, Conjugated (USP); Female; Humans; Leiomyoma; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Middle Aged; Prevalence; Uterine Neoplasms; Uterus; White People | 2011 |
Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression.
Topics: Estradiol; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Gonanes; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Mifepristone; Muscle Development; Myocytes, Smooth Muscle; Myometrium; Oligopeptides; Progestins; Steroids; Transforming Growth Factors | 2002 |
Depo medroxyprogesterone acetate (DMPA) therapy for uterine myomata prior to surgery.
Topics: Adult; Antineoplastic Agents, Hormonal; Dose-Response Relationship, Drug; Female; Hemoglobins; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Preoperative Care; Retrospective Studies; Uterine Neoplasms | 2004 |
Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study.
Topics: Adult; Female; Hemoglobins; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menorrhagia; Pilot Projects; Premenopause; Treatment Outcome; Ultrasonography; Uterine Neoplasms | 2004 |
Vulvar leiomyoma associated with estrogen/progestin therapy. A case report.
Topics: Adult; Bartholin's Glands; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Vulvar Neoplasms | 1995 |
Gene expression of epidermal growth factor in human endometrium during decidualization.
Topics: Blotting, Northern; Decidua; DNA Probes; Endometrium; Epidermal Growth Factor; Female; Gene Expression; Humans; In Situ Hybridization; Leiomyoma; Medroxyprogesterone Acetate; Pregnancy; Protein Precursors; RNA, Messenger; Uterine Neoplasms | 1994 |
Expression of connexin-43 in human myometrium and leiomyoma.
Topics: Adult; Cells, Cultured; Connexin 43; Estradiol; Female; Gap Junctions; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Muscle, Smooth; Myometrium; RNA, Messenger; Uterine Neoplasms | 1993 |
Uterine fibroids: protocols of integrated medical/surgical treatment.
Topics: Abortion, Habitual; Biopsy; Combined Modality Therapy; Estrogens, Conjugated (USP); Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Infertility, Female; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Pregnancy; Uterine Neoplasms; Uterus | 1993 |
Response of "benign" metastasizing leiomyoma to progestin withdrawal. Case report.
Topics: Female; Humans; Leiomyoma; Lung Neoplasms; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progesterone Congeners; Uterine Neoplasms | 1993 |
Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Topics: Adult; Amino Acid Sequence; Base Sequence; Cell Division; DNA; Estradiol; Female; Gene Expression; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Molecular Sequence Data; Muscle, Smooth; Myometrium; Receptors, LHRH; Transforming Growth Factor beta; Uterine Neoplasms | 1996 |
Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study.
Topics: Bone Density; Chemotherapy, Adjuvant; Delayed-Action Preparations; Drug Monitoring; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Progesterone Congeners; Uterine Neoplasms | 1997 |
[Intrauterine pregnancy with uterine myoma after downregulation with GnRH analogs].
Topics: Adult; Antineoplastic Agents; Buserelin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications, Neoplastic; Receptors, LHRH; Uterine Neoplasms | 1992 |
Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study.
Topics: Adult; Antineoplastic Agents; Bone Density; Buserelin; Cholesterol; Contraceptive Agents, Female; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Pilot Projects; Triglycerides; Uterine Neoplasms | 1991 |
Treatment of abnormal uterine bleeding with the gynecologic resectoscope.
Topics: Adult; Aged; Amenorrhea; Antineoplastic Agents; Catheterization; Danazol; Electrocoagulation; Endometrium; Female; Humans; Hysteroscopes; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Uterine Neoplasms; Uterus | 1991 |
Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
Topics: Drug Therapy, Combination; Endometriosis; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Uterine Neoplasms | 1990 |
Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study.
Topics: Bone and Bones; Climacteric; Drug Administration Schedule; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects; Ultrasonography; Uterine Neoplasms; Uterus | 1989 |